SEMAGLUTIDE MARKET ANALYSIS

Semaglutide MarketSize and Trends

Global Semaglutide Market – Dynamics

Increasing prevalence of type 2 diabetes is expected to boost growth of the global semaglutide market over the forecast period. For instance, according to article published by the Centers for Disease Control and Prevention (CDC), in 2017, around 23.1 million people in the U.S., were diagnosed with diabetes, out of which 132,000 were children and adolescents. The report also mentioned that out of the total diabetes cases, 90% to 95% accounted from type 2 diabetes.

Furthermore, various initiatives, campaigns, and programs launched by key players, in order to prevent and control diabetes are expected to propel the market growth over the forecast period. For instance, in 2014, Novo Nordisk, a global pharmaceutical company, and Steno Diabetes Center Copenhagen, London, launched ‘Cities Changing Diabetes’, a program designed to identify the areas and populations that are at greatest risk of getting affected by diabetes globally. Moreover, in November 2019, Philadelphia also joined the program and became the 25^th city globally to become a part of the Cities Changing Diabetes program.